PT  - JOURNAL ARTICLE
AU  - Baqal, Omar
AU  - Karikalan, Suganya A.
AU  - Hasabo, Elfatih A.
AU  - Tareen, Haseeb
AU  - Futela, Pragyat
AU  - Qasba, Rakhtan K.
AU  - Shafqat, Areez
AU  - Qasba, Ruman K.
AU  - Hayes, Sharonne N.
AU  - Tweet, Marysia S.
AU  - El Masry, Hicham Z.
AU  - Lee, Kwan S.
AU  - Shen, Win-Kuang
AU  - Sorajja, Dan
TI  - In-Hospital and Long-Term Outcomes in Spontaneous Coronary Artery Dissection (SCAD) with Concurrent Cardiac Arrest: A Systematic Review and Meta-Analysis
AID  - 10.1101/2024.09.25.24314406
DP  - 2024 Jan 01
TA  - medRxiv
PG  - 2024.09.25.24314406
4099  - http://medrxiv.org/content/early/2024/09/26/2024.09.25.24314406.short
4100  - http://medrxiv.org/content/early/2024/09/26/2024.09.25.24314406.full
AB  - Background Spontaneous coronary artery dissection (SCAD) is increasingly recognized as an important cause of myocardial infarction (MI). However, our understanding of clinical characteristics that predispose patients to worse outcomes, such as concurrent sudden cardiac arrest (CA), remains limited.Objective We performed a systematic review and meta-analysis of studies assessing clinical outcomes among SCAD patients with aconcurrent CA.Methods This study was performed according to PRISMA guidelines. PubMed, Cochrane, and Scopus were systematically searched using relevant search terms, such as “Spontaneous Coronary Artery Dissection”, “Ventricular Tachycardia”, “Ventricular Fibrillation”, “Sudden Cardiac Death” and “Cardiac Arrest”. The search was conducted from database inception to July 2024. Studies assessing the clinical outcomes of SCAD patients with concurrent CA were included. RevMan 5.4 was used for meta-analysis.Results After removal of duplicates, 269 studies underwent screening, out of which 10 studies were included (n= 3978 patients, 357 with CA). In-hospital mortality, post-discharge mortality, recurrent MI and recurrent SCAD occurred in 20%, 3%, 12% and 9% of SCAD patients with CA, respectively. When compared to SCAD patients without CA, SCAD patients with CA were at significantly higher risk of in-hospital mortality (RR = 6.75, 95% CI [4.50, 10.14], I2= 0%), post-discharge mortality (RR = 5.86, 95% CI [1.72, 19.91], I2=0%), recurrent MI (RR =3.31, 95% CI [2.03, 5.39], I2=56%), recurrent SCAD (RR = 1.91, 95% CI [1.11, 3.27], I2= 43%), acute heart failure (RR = 4.82, 95% CI [3.22, 7.20], I2=42%), and cardiogenic shock (RR = 6.11, 95% CI [4.07, 9.19], I2=64%). Out of a pooled 24 implanted cardiac defibrillators (ICDs) and 11 wearable cardiac defibrillators (WCDs), there was only one appropriate and one inappropriate ICD discharge recorded over the follow-up period.Conclusion In this cohort, SCAD with concurrent CA was associated with worse in-hospital and long-term outcomes including in-hospital and post-discharge mortality, acute heart failure, and recurrent MI and SCAD. There was a low long-term rate of administered defibrillator therapies among patients discharged from the hospital with an ICD or WCD. Further research is needed to better delineate optimal management approaches toward this high-risk patient population, including secondary prevention of sudden cardiac death.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo funding receivedAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Not applicableI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesNo new original data generated. Data utilized in current study available through manuscripts and supplemental material of included studies.